Contrast sensitivity in rats with increased or decreased numbers of retinal ganglion cells

Experimental Brain Research
C A HeywodA Cowey

Abstract

Contrast thresholds were measured electrophysiologically on striate cortex in normal rats and in rats in which either the superior colliculi were removed bilaterally or unilaterally at 5 days of age, or one eye was removed on the day of birth. Despite the fact that the collicular ablation leads to the degeneration of more than half the retinal ganglion cells, contrast sensitivity was normal in this group, with the possible exception of sensitivity at very low spatial frequencies below 0.1 c/deg. The result is strong evidence that retinal ganglion cells which project to thalamus as well as to mid-brain escape the degenerative effects of neonatal mid-brain lesions. The contrast sensitivity of neonatally operated one-eyed rats was significantly and substantially better than that of normal rats tested monocularly. The increased sensitivity was greatest in the cortex ipsilateral to the remaining eye. This supernormal sensitivity is presumably related to the increase in the number of ganglion cells in the remaining eye, especially those projecting ipsilaterally from the temporal retina and which show a five-fold expansion of their terminal zone in the thalamus.

Citations

Jan 1, 1989·Behavioural Brain Research·L C SilveiraA Cowey
Apr 24, 2001·The British Journal of Ophthalmology·W Westlake
Jan 1, 1996·Vision Research·J J NicholasA Cowey
Apr 13, 2018·Journal of Neurotrauma·Rachael S AllenMachelle T Pardue

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.